Michael M Ittmann

Michael M. Ittmann, M.D., Ph.D. is a Professor and William D. Tigertt Chair in Pathology at Baylor College of Medicine, where he also serves as Co-Leader of the Cancer Biology Program and Director of the Human Tissue Acquisition & Pathology Shared Resource at the Dan L Duncan Comprehensive Cancer Center. His research program focuses on molecular mechanisms of prostate cancer development and progression.

Dr. Ittmann's research interests center on molecular genetics of prostate cancer, particularly investigating fibroblast growth factor signaling pathways, DNA methylation changes in prostate cancer, and racial disparities between African American and Caucasian prostate cancer patients. His laboratory has made significant contributions to understanding the role of FGFR signaling in prostate cancer progression and metastasis, as well as the biological significance of the TMPRSS2/ERG gene fusion.

Dr. Ittmann's laboratory maintains active research funding from multiple sources including the Department of Defense Prostate Cancer Program and the Department of Veterans Affairs, with current projects focusing on enhancing radiation therapy outcomes, tumor microenvironment biomarkers in African American prostate cancer, and novel oncogenic pathways specific to African American prostate cancer.

His leadership roles include serving as Co-Leader of the Cancer Biology Program at the Dan L Duncan Comprehensive Cancer Center and Director of the Human Tissue Acquisition & Pathology Shared Resource, which provides critical infrastructure for prostate cancer research at Baylor College of Medicine.